Deinstitutionalisation

From WikiMD's WELLNESSPEDIA

Deinstitutionalisation refers to the process of replacing long-stay psychiatric hospitals with less isolated community mental health services for those diagnosed with a mental disorder or developmental disability. Deinstitutionalisation works on the principle that people will recover more quickly and integrate more effectively into society when treated in community-based facilities.

History[edit]

The process of deinstitutionalisation began in the mid-20th century, largely due to the introduction of antipsychotic medications and the recognition of the inhumane conditions in many psychiatric institutions. The Community Mental Health Act of 1963 was a significant catalyst in the United States, aiming to construct community mental health centers to care for people in their home communities.

Process[edit]

Deinstitutionalisation involves the gradual phasing out of institutional care and the transition to community-based care. This process includes the development of community mental health services, supported housing, and other support systems. It also involves the reintegration of individuals into the community, often through occupational therapy and social skills training.

Criticisms[edit]

While deinstitutionalisation has been praised for its humanistic approach, it has also faced criticism. Critics argue that community-based services are often inadequate and that many individuals with severe mental illnesses end up homeless or in prison. The phenomenon of transinstitutionalisation refers to this shift of care from psychiatric hospitals to jails and homeless shelters.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.